Dataset from A Multicenter, Randomized, Subject-Blind, Investigator-Blind Study to Evaluate the Time Course of Pharmacodynamic Response, Safety and Pharmacokinetics of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00010117
下载链接
链接失效反馈官方服务：
资源简介：
This is a Phase 2a, multicenter, randomized, subject-blind, investigator-blind, study to
investigate the pharmacokinetics (PK), pharmacodynamics (PD), and safety of bimekizumab in
adult subjects with moderate to severe chronic plaque psoriasis
创建时间：
2025-02-10
